课题基金 / 基金详情

NEUROVASCULAR CROSS-TALK, FUNCTIONS AND SOURCES OF SOLUBLE VEGF RECEPTORS IN OCULAR VASCULAR DEMARCATION

NEUROVASCULAR CROSS-TALK, FUNCTIONS AND SOURCES OF SOLUBLE VEGF RECEPTORS IN OCULAR VASCULAR DEMARCATION
眼血管分界中可溶性 VEGF 受体的神经血管交互作用、功能和来源
批准号:
9981117
负责人:
BALAMURALI K AMBATI
金额:
$6.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2020-07-24

项目摘要

项目成果

BALAMURALI K AMBATI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Visual clarity depends on strict vascular demarcations between ocular vascular beds and vision-critical tissues such as the cornea and macular photoreceptors. Our long-range goals are to elucidate the molecular network that maintains this compartmentalization in the eye and to understand how the network is altered in pathological ocular angiogenesis. Our immediate goal is to dissect tissue-specific differences in vascular versus neuronal requirements for vascular endothelial growth factor (VEGF) under normal and pathological conditions. We will determine how soluble VEGF receptors orchestrate cross-talk among corneal compartments to titrate the balance between VEGF requirements for vascular demarcation and neuronal homeostasis. We will genetically dissect the roles of specific ocular compartments to determine how VEGF-dependent nerve regeneration is accomplished without triggering a vascular breach. We will rigorously analyze the vascular response of soluble VEGFR1 (sFlt1) knockdown within each corneal compartment during epithelial wound healing and nerve regeneration. Complementing this analysis, we will dissect the roles of sVEGF receptors expressed on corneal neurons. Finally, we will elucidate whether splice shifting morpholinos conjugated to a neovessel-targeting peptide motif can treat corneal neovascularization (KNV) and choroidal neovascularization (CNV). Our specific aims for the next grant period are: Specific Aim #1: To rigorously test functional requirements for soluble VEGFR1 (sFlt1) or soluble VEGFR2 (sKDR) within specific corneal compartments for achieving vascular demarcation and appropriate innervation in the normal and injured cornea. Specific Aim #2: To determine whether aniridia-associated KNV resulting from Pax6 haploinsufficiency derives from neural crest related defects in the corneal stroma that shift angiogenic potential, and whether vascular breach from limbal stem cell deficiency is a secondary paracrine mechanism due to epithelial upregulation of MT2-MMP. Specific Aim #3: To determine whether local administration of RGD-conjugated splice shifting morpholino (cRGD.KDR.MO) can significantly increase sKDR/mKDR ratios and decrease neovascularization in laser-CNV injury and sutured corneas of wild type mice, and in Pax6+/- mouse corneas. These studies will define the tissue-specific functions of sFlt1 and sKDR in the context of competing requirements for neuronal and vascular homeostasis in the cornea, systematically detailing the development and maintenance of vascular zoning and neurite outgrowth in normal and pathological situations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COMP-Ang1: Vascular Normalization and Neuroprotection for Diabetic Retinopathy
  • 批准号:
    9004910
  • 项目类别:
  • 资助金额:
    $33.53万
  • 财政年份:
    2016
  • 负责人:
    BALAMURALI K AMBATI
  • 依托单位:
COMP-Ang1: Vascular Normalization and Neuroprotection for Diabetic Retinopathy
  • 批准号:
    9197294
  • 项目类别:
  • 资助金额:
    $33.53万
  • 财政年份:
    2016
  • 负责人:
    BALAMURALI K AMBATI
  • 依托单位:
Synergistic OEC-biologic Use for Diabetic Retinal Regeneration
Synergistic OEC-biologic Use for Diabetic Retinal Regeneration
海外基金